A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

This post was just published on ZYX Buy Change Alert.

On February 1st we issued a call to take profits on MNTA.  Depending upon how you traded, your profits would have been 74%.

We got out at the top.  Now the stock has fallen providing an opportunity to enter again.  The buy zone is $12 to $15.35, preferably below $14.31.  The stock is trading at $15.30 as of this writing. The target zone is $18 to $20, and $24 to $28 in the event of a buyout.  Stop zone on one-half of the position is $11 to $11.38.

Those who are not aggressive may consider accumulating only on a dip in the $12 range.

Recommended quantity is 30% of the full core position size.

MNTA is in the business of biosimilars.  In the world of biotechnology, biosimilars are just like generics in the traditional pharmaceutical world.  The difference is that making a biosimilar is much more difficult than making a generic.

Most of the movements in this stock result from ups and downs related to its drug Glatopa.  Glatopa is a biosimilar to Copaxone.  Copaxone is a highly popular MS drug from TEVA.

The drop in MNTA stock has resulted from an FDA warning letter to PFE.  PFE is the manufacturing partner for MNTA.

In our analysis, PFE should be able to resolve the issue in the near future.  However the risk in MNTA stock has increased as other companies are on its heels to develop a biosimilar for Copaxone.  For this reason those who are not aggressive need to wait for a dip into the $12 range; of course such a dip may never happen.  Those who are aggressive may consider scaling in by starting a very, very small position right here.  Please see Trade Management Guidelines.

 

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

HERE IS HOW TO TAKE LESS RISK AND STILL PROFIT BIG FROM HOT SECTORS – MARIJUANA, GREEN ENERGY AND SEMICONDUCTORS

  There are big rewards from investing in hot sectors.  However, individual stocks in hot sectors present significant risks. Fortunately, there is ...

169% PROFIT – SEMICONDUCTORS, MARIJUANA AND GREEN ENERGY – BUY ZONES ARE POWERFUL

  ETFs have less risk than individual stocks. Several ETFs are now providing opportunities as they fall into buy zones. Buy zones ...

MORE GAINS AHEAD – 63% GAIN ON THIS SUPPLIER OF A KEY COMPONENT FOR VACCINE

  Maravai LifeSciences (MRVI) is long from $25.84.   MRVI is trading at $42.25 as of this writing.  This represents a gain of ...

CORONAVIRUS IS PROVIDING OPPORTUNITIES IN STOCKS YOU HAVE NEVER HEARD OF

Coronavirus is providing opportunities for investors beyond well-known names.  A good example is a stock that most investors have never ...

WEEKLY STOCK MARKET DIGEST: PROTECT YOURSELF, POLITICIANS TURNING KING DOLLAR INTO POOR DOLLAR

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE

Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine ...

WEEKLY STOCK MARKET DIGEST: AN IMPORTANT CHART THAT ALL INVESTORS SHOULD WATCH BUT ARE NOT WATCHING

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

VACCINE APPROVED IN U. K. — A VERY PROFITABLE SHORT TERM TRADE ON THE VACCINE STOCK MODERNA

The big news is that the vaccine from Pfizer (PFE) and BioNTech (BNTX) has been approved in the U. K. The ...

WEEKLY STOCK MARKET DIGEST: STOCK MARKET EXCITED ABOUT YELLEN — HEAVY BORROWING AHEAD

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

WEEKLY STOCK MARKET DIGEST: MORE MONEY PRINTING AHEAD SAVES THE STOCK MARKET FROM A BIG DIP

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

THE STOCK MARKET ‘TELL’ FROM MORE GOOD NEWS ON VACCINE AND BOEING’S 737 UNGROUNDED

To gain an edge, this is what you need to know today. Tepid Reaction Please click here for a chart of S&P ...

STOCK MARKET INVESTORS: 94.5% VACCINE EFFICACY AND CHINA’S TRIUMPH OVER THE U. S. — PAY ATTENTION

Vaccine And Trade Deal Please click here for a chart of S&P 500 ETF (SPY) which represents stock market benchmark index ...

WEEKLY STOCK MARKET DIGEST: PRUDENT INVESTORS PAY ATTENTION TO THE FASTEST ROTATION

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

VERY EFFECTIVE COVID-19 VACCINE — HERE IS THE GAME PLAN FOR PRUDENT INVESTORS NOW

To gain an edge, this is what you need to know today. Reduce Cash And Hedges Both cash and hedge levels are ...

WEEKLY STOCK MARKET DIGEST: TRADER MAGNET AHEAD, CONSUMER SPENDING SPREE INDICATES GOOD CHRISTMAS

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

WEEKLY STOCK MARKET DIGEST: FINALLY SOME INVESTORS GETTING CONCERNED ABOUT THE FED, RED HOT HOUSING MARKET COOLS $SPY $DJIA $DIA

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

HOW WILL STOCK MARKET AND GOLD REACT TO TRUMP’S NEW ANNOUNCEMENT OF CORONAVIRUS BREAKTHROUGH? $AAPL $AMZN $NVAX $AAL $CCL $BNTX $MRNA $PFE $INO $ZM

This is what you will need to know today. Trump will announce at 6:00 pm ET a breakthrough therapeutic for coronavirus.  ...

WEEKLY MARKET DIGEST: GOLD AT RECORD HIGH AS INVESTORS MOVE TO PROTECT STOCK MARKET PORTFOLIOS $DJIA $SPX $QQQ $GLD $SLV $USO $GDX $AZN

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

VACCINE IS GOOD FOR EVERYBODY BUT NOT FOR YOUR FAVORITE STOCKS $INO $PFE $NVAX $NIO $MRNA $AZN $TSLA $AMZN $DIA $DJIA $FSLY $PTON $ZM $DOCU $MSFT $GOOG $NFLX

We all want a safe and effective vaccine for the coronavirus. Certainly one or more effective vaccines will be good ...

WEEKLY MARKET DIGEST: A BREAK ABOVE THE UPPER BAND, RECORD COMPLACENCY AMONG TRADERS $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights ...

Follow

Get every new post delivered to your Inbox

Join other followers